Boditech Med Statistics

Total Valuation

Boditech Med has a market cap or net worth of KRW 308.97 billion. The enterprise value is 260.82 billion.

Market Cap	308.97B
Enterprise Value	260.82B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Boditech Med has 21.98 million shares outstanding. The number of shares has decreased by -0.65% in one year.

Shares Outstanding	21.98M
Shares Change (YoY)	-0.65%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	36.16%
Owned by Institutions (%)	1.84%
Float	13.89M

Valuation Ratios

The trailing PE ratio is 10.15 and the forward PE ratio is 8.49.

PE Ratio	10.15
Forward PE	8.49
PS Ratio	2.22
PB Ratio	1.48
P/FCF Ratio	12.94
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.67, with an EV/FCF ratio of 10.92.

EV / Earnings	8.57
EV / Sales	1.87
EV / EBITDA	6.67
EV / EBIT	8.45
EV / FCF	10.92

Financial Position

The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.06.

Current Ratio	5.51
Quick Ratio	4.04
Debt / Equity	0.06
Debt / EBITDA	0.32
Debt / FCF	0.52
Interest Coverage	93.81

Financial Efficiency

Return on equity (ROE) is 15.28% and return on invested capital (ROIC) is 9.01%.

Return on Equity (ROE)	15.28%
Return on Assets (ROA)	8.36%
Return on Capital (ROIC)	9.01%
Revenue Per Employee	282.79M
Profits Per Employee	61.87M
Employee Count	492
Asset Turnover	0.61
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.38%
50-Day Moving Average	17,636.20
200-Day Moving Average	17,043.85
Relative Strength Index (RSI)	22.43
Average Volume (20 Days)	153,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Boditech Med had revenue of KRW 139.13 billion and earned 30.44 billion in profits. Earnings per share was 1,385.31.

Revenue	139.13B
Gross Profit	84.34B
Operating Income	30.45B
Pretax Income	35.70B
Net Income	30.44B
EBITDA	38.66B
EBIT	30.45B
Earnings Per Share (EPS)	1,385.31

Full Income Statement

Balance Sheet

The company has 72.07 billion in cash and 12.35 billion in debt, giving a net cash position of 59.71 billion or 2,717.35 per share.

Cash & Cash Equivalents	72.07B
Total Debt	12.35B
Net Cash	59.71B
Net Cash Per Share	2,717.35
Equity (Book Value)	219.78B
Book Value Per Share	9,475.02
Working Capital	115.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.09 billion and capital expenditures -8.21 billion, giving a free cash flow of 23.88 billion.

Operating Cash Flow	32.09B
Capital Expenditures	-8.21B
Free Cash Flow	23.88B
FCF Per Share	1,086.45

Full Cash Flow Statement

Margins

Gross margin is 60.62%, with operating and profit margins of 21.88% and 21.88%.

Gross Margin	60.62%
Operating Margin	21.88%
Pretax Margin	25.66%
Profit Margin	21.88%
EBITDA Margin	27.78%
EBIT Margin	21.88%
FCF Margin	17.16%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.42%.

Dividend Per Share	200.00
Dividend Yield	1.42%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	14.44%
Buyback Yield	0.65%
Shareholder Yield	2.07%
Earnings Yield	9.85%
FCF Yield	7.73%

Dividend Details

Stock Splits

The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 5, 2017
Split Type	Forward
Split Ratio	1.1

Scores

Boditech Med has an Altman Z-Score of 9.96.

Altman Z-Score	9.96
Piotroski F-Score	n/a